Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tech Transfer Roundup: MD Anderson Working To Unlock Promise Of Tumor-Infiltrating Lymphocytes

Mar 12 2021

• By Joseph Haas

Tech Transfer

Related Content

Regenerative Medicine Comes Of Age – In The Age Of COVID-19

Dec 01 2020

Tech Transfer Roundup: MD Anderson Tackles Cancer In Alliances With UroGen, Xencor, Obsidian

Feb 12 2021

Levo Product Joins List Of Prader-Willi Syndrome Trial Failures

Aug 10 2020

Encouraging Signals For New Cancer Cell Therapy Strategies

Apr 30 2020

Related Companies

University of Texas MD Anderson Cancer Center

Iovance Biotherapeutics, Inc.

Obsidian Therapeutics, Inc.

Novartis AG

Kite Pharma, Inc.

Mirati Therapeutics, Inc.

Orionis Biosciences Inc.

Soleno Therapeutics, Inc.

Vanderbilt University

Silo Pharma, Inc.

University of Maryland, Baltimore

SHEPHERD Therapeutics, Inc

Mayo Clinic

Tonix Pharmaceuticals Holding Corp.

Taysha Gene Therapies, Inc.

Cleveland Clinic

UT Southwestern Medical Center

Rockefeller University

Bristol Myers Squibb Company

Sorrento Therapeutics, Inc.

Icahn School of Medicine

Vaxalto Biotherapeutics, Inc.

PharmaTher, Inc.

University of Kansas

Qualigen Therapeutics, Inc.

University College London

University of California, Los Angeles

Xencor, Inc.

Genentech, Inc.

University of California San Francisco

University of California, Berkeley

University of Washington

Kyowa Kirin Co., Ltd.

Harvard University

Exscientia plc

University of Oxford

Repertoire Immune Medicines

Dana-Farber/Harvard Cancer Center

Additional Topics

Deals Business Strategies ImmunoOncology Commercial Tech Transfer Round-Up Cancer BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window